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ReviewUpstream Regulation of the Hippo SizeFelix A. Grusche1,2,3, Helena E. Richardson2,3,4,
and Kieran F. Harvey1,5,*
The newly discovered Salvador–Warts–Hippo (SWH)
pathway is a key regulator of tissue growth during both
development and disease. The first identified components
of this pathway represent core downstream effector
proteins: the kinases Warts and Hippo; the adaptor
proteins Salvador and Mats; and the transcriptional co-
activator Yorkie. More recently, a surprising number of
proteins have been implicated as upstream regulators of
the SWH pathway, including: the planar cell polarity cad-
herins Fat and Dachsous; the FERM-domain proteins
Expanded and Merlin; the WW-domain protein Kibra; the
Ras-association family protein dRASSF; and the apico-
basal polarity proteins lethal giant larvae, atypical protein
kinase C and Crumbs. The identification of a large cohort
of upstream regulatory proteins suggests that core SWH
pathway proteins are poised to respond to diverse stimuli
that must be integrated in a coordinated fashion. Here, we
review the existing knowledge of upstream SWH pathway
proteins and discuss possible mechanisms of action and
signal integration.
Introduction
How multicellular organisms orchestrate the growth of their
individual cells and organs is a fundamental question that
has fascinated generations of biologists. In recent years,
a great deal has been learned about tissue growth control,
but it is clear that our understanding of this process is far
from complete. The identification of a novel signalling
network — the Salvador–Warts–Hippo (SWH) pathway —
as a crucial determinant of organ size has provided a new
entry point into the question of organ-size control [1]. The
SWH pathway was first discovered in Drosophila mela-
nogaster and was subsequently shown to play a similar
growth-regulatory role in mice [1–3]. In addition, deregula-
tion of SWH pathway activity has been implicated in the
formation of different types of human cancer [4,5]. This
suggests that the growth-regulatory activity of the SWH
pathway is conserved in humans, and that therapeutic
modulation of SWH pathway activity represents a viable
option to modulate aberrant tissue growth in human hyper-
trophic diseases or in cancer.
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components of this pathway and can be broadly classified
into core, downstream and upstream members (Figure 1).
Proteins that constitute the core kinase module of the SWH
pathway were identified in Drosophila genetic screens on
the basis that their loss led to egregious tissue growth. These
proteins are the Ser/Thr kinases Warts (Wts) and Hippo
(Hpo), and the adaptor proteins Salvador (Sav) and Mob as
tumour suppressor (Mats) [1,6–12]. Core SWH pathway
proteins repress tissue growth largely by phosphorylating,
and thereby inhibiting, the growth-promoting transcriptional
co-activator Yorkie (Yki) [13]. Yki promotes growth by modu-
lating the activity of transcription factors, and together these
proteins can be classified as downstream SWH pathway
members. In recent years, an increasingly complex picture
has emerged with regards to the growth-regulatory role of
both downstream and upstream SWH pathway proteins.
At least three transcription factors — Scalloped [14–16],
Homothorax and Teashirt [17] — have been reported to
mediate the growth-regulatory function of Yki, whilst further
transcriptional regulatory proteins are likely to exist [18,19].
Several reviews have distilled our current knowledge of
core SWH pathway proteins [4,5,20,21]. The focus of this
review is to highlight a spate of recent reports that has
described a growing number of proteins that regulate the
core SWH pathway kinase cassette and Yki. Such proteins
can be broadly termed upstream SWH pathway proteins.
The majority of these proteins can be grouped into three
major categories: proteins that signal via the atypical cad-
herin, Fat, which functions as a transmembrane receptor
for the SWH pathway; the Kibra–Expanded–Merlin complex,
which has recently been shown to provide a direct link from
the apical membrane to core SWH pathway proteins; and the
apicobasal polarity proteins (Figure 1). Upstream regulators
are clustered on the basis of their mutant phenotypes
(Figure 2) and by their physical interactions (Table 1), but
proteins from each branch display evidence of interfacing
with members of other branches (Figures 1 and 3).
As described below, an increasingly complex picture is
emerging of the mechanism by which upstream regulatory
proteins ‘fine-tune’ growth regulation by the SWH pathway.
Fat Signalling outside the Cell — Fat, Dachsous
and Four-jointed
Fat (Ft) and Dachsous (Ds) are atypical cadherins that control
organ growth, planar cell polarity and proximal–distal
patterning [22–27]. Mutation of ft and, to a lesser degree,
mutation of ds results in tissue overgrowth [22,28]. In 2006,
work by several groups revealed that Ft controls growth
upstream of the SWH pathway [29–31]. With this discovery,
a transmembrane receptor for the SWH pathway had been
revealed that could potentially relay extracellular signals
through to the core components of the pathway.
More recently Ds was shown to control growth via the
SWH pathway by functioning as a ligand for Ft [32,33],
a finding that extended the functional link between these
proteins, which had previously been shown to interact [34],
influence each other’s localisation [35], and co-ordinately
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Figure 1. The SWH signalling pathway in
Drosophila melanogaster.
Interactions between different components of
the SWH pathway are shown (positive interac-
tions are signified by arrows, whereas inhibitory
interactions are indicated by blocked lines).
Lethal giant larvae (Lgl) and atypical protein
kinase C (aPKC) affect localisation of Hippo
(Hpo) and Drosophila Ras association family
protein (dRASSF) but the functional conse-
quence is unclear. Proteins in green activate
Yorkie (Yki), while proteins in red inhibit Yki.
The SWH pathway controls tissue growth by
regulating the subcellular localisation of Yki,
which, when nuclear, associates with cognate
transcription factors (TFs), and activates a tran-
scriptional program that drives cell growth and
proliferation, and inhibits apoptosis. Several
upstream inputs regulate the activity of the
core SWH components Salvador (Sav), Hpo,
Warts (Wts) and Mob as tumour suppressor
(Mats). Fat (Ft)-dependent signalling is dis-
played on the left side of the cell. Ft signals to
the core components by controlling the localisa-
tion of Dachs (D) and by influencing the localisa-
tion and levels of Expanded (Ex). Ft activity is
controlled by its ligand Dachsous (Ds), by the
kinases Four-jointed (Fj) and Discs overgrown
(Dco), and by Lowfat (Lft), Approximated (App)
and Dachs (D). Kibra, Ex and Merlin (Mer) form
a complex that is depicted on the right side of
the cell, along with dRASSF and the apicobasal
polarity proteins, Crumbs (Crb), aPKC and Lgl.
For a complete overview of protein–protein
interactions between pathway members refer
to Table 1.
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R575regulate planar cell polarity (reviewed in
[36,37]). Interestingly, activation of the
Ft receptor by Ds does not occur in a
classical ligand-concentration-depen-
dent manner. Instead, it appears that
relative levels of Ft and Ds between cells
control the activity of Ft [32,33]. For example, when cells ex-
pressing high levels of Ds are placed next to cells expressing
low levels of Ds, activation of SWH pathway target genes
ensues on both sides of the boundary between high and
normal Ds expression [32,33]. This clonal boundary effect
is seen several cell diameters away from the clone, suggest-
ing that the signal can be propagated from one cell to its
neighbours, possibly via cell-surface interactions between
Ft and Ds. The binding of Ft and Ds is modulated by the
kinase Four-jointed (Fj). Fj phosphorylates Ft and Ds on their
extracellular domains as they are trafficked through the Golgi
apparatus and thereby modifies the Ft–Ds interaction [38].
Interestingly, Fj appears to have a dual role in modulating
Ft–Ds binding. By phosphorylating Ds, it reduces the ability
of Ds to bind to Ft [39,40], whereas by phosphorylating Ft it
increases Ft’s ability to bind to Ds [40]. The opposing roles
of Fj on Ft and Ds could thus cause polarisation of Ft activity
within cells, and this is thought to be required for Ft’s func-
tion in size control (for a model, refer to [40]). Ds and Fj are
expressed in complementary gradients in many tissues of
Drosophila [34,41], and their expression levels are controlled
by morphogens such as Wingless (Wg) and Decapentaplegic
(Dpp) [26,33]. The discoveries that morphogens regulate thegraded expression of Ds and Fj, and that Ds and Fj in turn
control Ft activity, leading to tissue-growth regulation
through the SWH pathway, provide an attractive model for
how organ growth is controlled by the SWH pathway down-
stream of morphogens [42].
Interestingly, there is evidence that Ds functions not only
as a ligand but also as a receptor [32,43]. Ds-overexpressing
clones in ds mutant discs result in the upregulation of SWH
pathway target genes only at the clonal border on the inside
of the clone, where Ds is present. Unlike the situation in the
wild-type disc, no clonal boundary effect is seen on the
outside of the clone [32]. Furthermore, ft, ds double mutant
discs are more overgrown than ft or ds single mutant discs
[28]. Whether Ds signals cell-autonomously via the SWH
pathway to control tissue growth, and whether this signal
is also relayed through the intracellular transducer of Ft sig-
nalling, termed Dachs (D), remains to be established. The
tissue overgrowth of ds mutants is a lot weaker than that of
ft mutants, suggesting either that Ft can signal in a partially
ligand-independent fashion or that other growth-regulatory
Ft ligands also exist.
Two potential mechanisms have been described by which
Ft can regulate SWH pathway activity (Figure 1): Ft influences
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Figure 2. Phenotypes of core versus upstream
regulators of SWH pathway signalling.
(A) Wild-type Drosophila head. (B) Drosophila
head in which the core SWH component, sav,
is mutated, resulting in severe overgrowth
and folding of the eye and head capsule. (C)
Drosophila head in which the upstream SWH
component ft is mutated, resulting in mild
overgrowth of the eye and head capsule.
Current Biology Vol 20 No 13
R576Wts protein stability, as revealed by the finding that Wts
levels are greatly reduced in ft mutant tissue [44]; or Ft regu-
lates the levels and subcellular localisation of Ex, given that
Ex protein levels are reduced and/or shifted to a more sub-
apical region in ft-deficient tissue [29–31]. Both of these
phenotypes depend on D (see below) [44,45]. Research
from the McNeill and Irvine laboratories added a new twist
to Ft signalling: they found that Ft protein is proteolytically
cleaved at the base of its extracellular domain, and that the
resultant cleavage products formed heterodimers [46,47].
This phenomenon is reminiscent of cleavage of the Notch
receptor protein, although the biological significance of Ft
cleavage and the mechanism by which it is regulated are
currently unclear.Fat Signalling inside the Cell — Discs overgrown
and Lowfat
Ft is not only phosphorylated at its extracellular domain by
Fj, but also at its intracellular domain (ICD) by the casein
kinase Discs overgrown (Dco) [46,47]. The phosphorylated
form of Ft-ICD seems to be active in growth suppression
because mutation of either dco or the Ft ligand ds
corresponds with reduced Ft-ICD phosphorylation and
stimulation of Yki-dependent tissue overgrowth. Although
phosphorylation of Ft-ICD is reduced in tissue homozygous
for the dco3 mutation, it is not abolished, suggesting the
presence of other Ft-ICD regulatory kinases [46,47]. How is
phosphorylation of Ft-ICD regulated? It has been previously
shown that Ft and Ds recruit each other to membrane [34].
Taken together with the observations that Ds promotes
phosphorylation of Ft [46,47] and that the Ft-ICD can form
dimers when overexpressed in HEK293 T cells [47], Sopko
and colleagues suggested that Ds promotes clustering of
the Ft receptor, and that this clustering might be required
for efficient Ft phosphorylation [47]. Dco phosphorylates
Ft-ICD at multiple residues, but at present the specific phos-
phorylation sites and their biological significance have not
been identified. Analysis of Ft’s phosphorylation sites should
shed further light on how Ft signals to downstream effectors
to control planar cell polarity and SWH pathway signalling.
Another open question regarding Ft-Ds signalling relates to
the regulation of Ds. The ICD of Ds, which is similar to that
of Ft, was found to be phosphorylated in both Drosophila
embryos and cultured cells [48,49], but the biological func-
tion of this phosphorylation, and its relevance to Ft signalling
have not been explored.
Ft and Ds activity are not only regulated by phosphoryla-
tion, but also through regulation of their protein stabilities.
This regulation is mediated by the cytoplasmic protein Low-
fat (Lft). Lft has no known domains [50] and was identified asa regulator of Ft and Ds by virtue of its interaction with these
proteins in a genome-wide yeast two-hybrid screen [51]. Lft
regulates the protein stability of Ft and Ds; loss of Lft strongly
reduces Ft and Ds protein levels. Conversely, overexpres-
sion of Lft increases levels of Ft and Ds and, reciprocally,
overexpression of either Ft or Ds increases levels of Lft,
whereas loss of Ft or Ds decreases Lft levels [50]. These
effects appear to be post-transcriptional since knockdown
of Ft by RNA interference does not influence lft transcript
levels and knockdown of Lft does not influence ft transcript
levels [50]. Interestingly though, lft transcript levels are
reduced when Notch and Wg signalling are disrupted [50],
suggesting that Lft might be a potential integrator of
morphogen signalling and SWH signalling. The mechanism
by which Lft affects Ft and Ds protein levels is unclear but
it might rely on direct protein–protein interactions, as Lft
co-precipitates with both Ft and Ds when expressed in S2
cells [50]. Given the strong effect that Lft has on Ft and Ds
protein stability, it is surprising that lft mutants are viable
with no obvious tissue overgrowth phenotype. Mao and
colleagues [50] speculate that this could be due to two
reasons: first, even though Ft protein levels are greatly
reduced in lft mutants, the small amount of remaining Ft
protein might be sufficient for Ft activity; second, loss of lft
reduces levels of both Ft and Ds. The partial loss of Ft could
be offset by the partial loss of Ds, since Ds appears to
regulate Ft depending on the steepness of its expression
gradient. A steep gradient of Ds inactivates Ft whereas
a shallow gradient activates it [32,33]. One could imagine
that a general reduction of Ds levels would flatten its expres-
sion gradient and thus activate Ft signalling.Relaying Fat Signalling to the Core — Dachs
and Approximated
How does Ft signal to the core components of the SWH
pathway? While no direct physical link has been described
between Ft and downstream SWH pathway proteins
(Table 1), genetic epistasis experiments place D between
Ft and the core components of the SWH pathway (Figure 1).
D is an unconventional myosin that functions downstream of
Ft in the regulation of SWH signalling. d loss-of-function
clones have the opposite phenotype to ft loss-of-function
clones: they grow poorly and d deficiency is epistatic to ft
deficiency, meaning that ft, d double mutant clones have
a d-like phenotype [44,45]. Therefore, D acts as a negative
regulator of SWH signalling, which is opposed by Ft
signalling.
How does D transduce signals from Ft? D has been
demonstrated to interact with Wts in S2 cells, which led to
the suggestion that D can directly promote Wts turnover
Table 1. SWH pathway members in Drosophila and humans and their interaction partners.
Drosophila Human Protein type Physical interaction partners of Drosophila proteins [Ref.]
Dachsous DCHS1,2 Atypical cadherin Lft [50], Ft [34], Fj [39]
Fat Ft1–4 Atypical cadherin Ft-ICD, Dco [46,47], Lft [50], Ds [34], Fj [39]
Four-jointed Fjx1 Golgi Ser/Thr kinase Ds, Ft [38,39]
Discs overgrown CKId, CKI3 Casein Ser/Thr kinase Ft-ICD [46,47]
Lowfat LIX1, LIX1L Regulator of Fat, Dachsous Ft, Ds [50]
Dachs ? Atypical myosin Wts [44]
Approximated ? DHHC palmitoyltransferase –
Kibra KIBRA WW-domain protein Mer [60–62], Ex [61,62], Sav, Hpo [62], Wts [61]
Expanded WILLIN/FRMD6 FERM-domain protein Kibra [61,62], Hpo [62], Mer [61,95], Yki [65,66]
Merlin MER/NF2 FERM-domain protein Kibra [60–62], Ex [61,95], Sav [62]
dRASSF RASSF1–10 Ras association domain family Hpo [68]
Lgl Lgl1,2 Scaffolding protein –
aPKC aPKCl,z Atypical Ser/Thr kinase –
Crumbs Crb1–3 Transmembrane protein –
Hippo MST1,2 Sterile-20 Ser/Thr kinase Sav [6,7,10], Yki [66], Ex, Kibra [62], dRASSF [68]
Salvador WW45/SAV1 Scaffolding protein Hpo [6,7,10], Wts [1,6,10], Mer, Kibra [62]
Warts LATS1,2 NDR family Ser/Thr kinase Sav [1,10], Mats [12], Dachs [44], Yki [13], Kibra [61]
Mats MOBKL1A,B NDR kinase family co-factor Wts [12]
Yorkie YAP, TAZ Transcriptional co-activator Ex [65,66], Hpo [66], Wts [13,66], Sd [14–16]
Scalloped Tead1–4 Transcription factor Yki [14–16]
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R577[44]. Exactly how D promotes Wts turnover is an important
issue that needs to be resolved in order to fully understand
the Ft–Wts arm of the pathway. Also pertinent to D function
is its localisation: D has a polarised localisation within imag-
inal disc cells, localizing preferentially to the distal side of
cells in a manner modulated by Ft, Ds and Fj [33,44]. The
subcellular localisation of D has been proposed to regulate
SWH pathway activity, repressing Ft signalling where D
levels are high and permitting Ft signalling where D levels
are low [33]. In apparent conflict with this model, D localisa-
tion was shown to be unchanged in dco3 mutant clones [46],
which are known to have impaired Ft signalling [46,47]. It is
possible that this highlights an alternative mode of Ft signal-
ling to the core SWH pathway module that is independent of
D localisation.
Another recently discovered regulator of Ft signalling is
the DHHC palmitoyltransferase Approximated (App). Like
D, App antagonises Ft signalling, as loss of App partially
suppresses the tissue overgrowth caused by ft deficiency
[52]. App appears to act by regulating the levels and
localisation of D; app clones show reduced levels and mis-
localisation of D protein, and overexpression of App
increases D levels at the subcellular membrane [52]. The
effects of App on D localisation appear to be mediated by
an as yet unidentified binding partner of D, given that there
is no evidence that App directly palmitoylates D [52].
Fat Signalling and the SWH Pathway in Mammals
Core components of the SWH pathway have been shown to
play a growth-regulatory role in both vertebrates and inverte-
brates, and the mechanism of signalling between these
proteins is also largely conserved [4,5,20,21]. To date,
however, a definitive link between components of the Ft sig-
nalling branch and tissue growth has not been reported in
mammals. Mammalian homologues of Ft, Ds, and Fj exist;
dchs1 and fjx1 are expressed in opposing gradients, mirror-
ing the expression patterns of their Drosophila homologues
Ds and Fj [53,54]. Loss of ft4, the closest homologue to
Drosophila Ft, leads to defects in oriented cell division and
planar cell polarity signalling, as well as upregulation of fjx1
[55]. Thus, it appears that the roles of Ft, Ds and Fj in planar
cell polarity signalling are conserved in mammals.Furthermore, Ft4 and Dchs1 interact in a heterophilic fashion
in mammalian cultured cells [56]. However, whether they
control tissue growth via the SWH pathway in vertebrates
requires further investigation. Of note, ft4 and ft1, another
ft homologue, are candidate tumour suppressor genes in
breast cancer and oral cancer, respectively [57,58].
Evidence for a role of downstream Ft signalling compo-
nents is lacking in vertebrates. Casein kinase 1 d and 3
(CK1d/3) — the mammalian homologues of Drosophila
Dco — co-precipitate with FT4 when expressed in HEK293
T cells, but the functional significance of this interaction
has not been explored [47]. Lft has two mammalian homo-
logues, Limb expression 1 (Lix1) and Lix1-like (Lix1L) [50].
Both of these can interact with Ft4 when expressed in
Drosophila S2 cells, and expression of Lix1L can rescue
the wing defect of lft mutants in Drosophila, suggesting
that LIX1L can functionally replace Lft [50]. The relevance
of D regulation for SWH signalling in vertebrates is presently
unclear, as no obvious functional homologue of D has been
identified in vertebrates.
The Kibra–Expanded–Merlin Complex
Three proteins that are predominantly located at the sub-
apical region of the cell are thought to provide input into
the SWH pathway in a largely Fat-independent manner
(Figure 1). These are the two FERM (4.1/ezrin/radixin/moe-
sin) domain-containing proteins Merlin (Mer) and Expanded
(Ex) [59], as well as the recently described WW-domain-con-
taining protein Kibra [60–62]. Three recent studies identifying
Kibra as a key protein acting upstream of the SWH pathway
have provided a major advance to our understanding of SWH
pathway signalling [60–62]. As well as defining a new
pathway member, these studies have helped to flesh out
a conceptual picture of how upstream pathway members
control activity of the core kinase module (Figure 1). Kibra
binds to both Mer and Ex, and together these proteins are
likely to recruit the core SWH pathway proteins to the apical
membrane for activation [60–62]. Interestingly, multiple inter-
actions were identified between the Kibra–Ex–Mer complex
and the core complex (Table 1): Mer bound Sav; Kibra bound
Sav and Wts; and Ex bound Hpo [61,62]. The requirement for
multiple interactions between Kibra–Ex–Mer and core
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enable multiple upstream inputs that signal via either Kibra,
Mer or Ex to be coupled to the core complex, or alternatively
they might provide a safeguard against loss of activity of
a single Kibra–Ex–Mer complex member. Evidence for such
a safeguard is provided by the fact that Kibra, Ex and Mer
can at least partially compensate for each other’s loss
[59–62]. Presumably this is because interaction between
the Kibra–Ex–Mer complex and the core complex is
perturbed, but not destroyed, when activity of only one
Kibra–Ex–Mer complex protein is lost.
The precise mechanism by which proteins of the
Kibra–Ex–Mer complex are regulated is unclear; they might
respond to a receptor(s) and/or a physical property of the
cell (see section on cell tension below). Several studies
suggest that the recruitment of the core complex to the
apical membrane is important for activation, but the mecha-
nism by which the Kibra–Ex–Mer complex activates the core
complex is currently obscure. Given that Wts and Ex both
bind Yki, and Kibra binds Wts, one possibility is that
Ex recruits Yki to the apical membrane and passes it to
Wts to be phosphorylated. Another possibility is that Wts
and Yki associate with each other (either in the nucleus or
cytoplasm) and are recruited together to a pre-assembled
Kibra–Ex–Mer complex that also contains Sav, Hpo and
Mats. Once Wts and Yki assemble into the complex, Wts
would be stimulated to phosphorylate Yki. The latter
scenario, which predicts an accessory role for Ex, rather
than a rate-limiting role, is supported by the stronger over-
growth phenotype of tissue lacking wts versus ex, as well
as the compensatory relationship observed between Ex,
Mer and Kibra. Further support for this model comes from
the finding that Kibra affects Wts activity, but not Wts–Yki
binding, at least in cultured Drosophila cells [61].
Kibra, Ex and Mer also appear to have the potential to influ-
ence each other’s activity: Kibra can promote Mer–Ex
binding, whereas Ex potentiates Kibra–Mer binding [61,62].
This relationship is particularly interesting in view of the
fact that deficiency of either kibra, ex or mer affects SWH
pathway activity in a temporally restricted and tissue-
specific fashion. mer or kibra deficiency leads to greater
Yki activation in ovarian follicle cells than ex deficiency,
whilst the converse is true in larval imaginal discs [60–62].
In addition, Ex and Mer appear to control SWH pathway
activity in the developing Drosophila eye in a temporally
restricted fashion: ex deficiency causes stronger Yki activa-
tion in the larval eye than in the pupal eye [63], and mer, but
not ex, is partially required for developmental apoptosis of
pupal retinal cells [29,64]. The activity profile of Ex correlates
with its expression profile, which is downregulated as eye
development proceeds [63]. One possibility is that different
thresholds of Yki activity are required throughout eye devel-
opment to mediate different biological events and that
Ex plays a major role in specification of Yki activity. We hy-
pothesise that, in the larval eye when cells are growing and
proliferating, high Ex levels are required to maintain a certain
level of SWH pathway activity, whereas in the pupal eye low
Ex levels allow a different level of Yki activity that is required
to control apoptosis and differentiation of post-mitotic
neurons and interommatidial cells. In the pupal eye, lowering
the expression levels of Ex would be expected to increase
Yki activity in three ways: Ex’s ability to activate the core
complex would be lowered; Mer–Kibra binding would be
weakened, also causing a reduction in activation of the corecomplex; and inhibition of Yki, mediated by direct interaction
with Ex, would be relieved. A greater understanding of the
regulation of activity and expression levels of Kibra, Ex and
Mer will help to clarify their tissue- and stage-specific roles.
Inhibition of Yorkie by Expanded — Short-Circuiting
the Core Complex
As well as promoting activity of the core SWH complex, Ex
can directly associate with Yki and inhibit its function
(Figure 1), possibly by sequestering Yki at the apical junction
[65,66]. The dual Yki-inhibitory roles of Ex are curious from an
evolutionary perspective; what would be the advantage of
a protein evolving two independent modes to repress
activity of the same protein? The answer to this is not clear,
but it is interesting that the likelihood of both of these modes
being conserved in mammals is low, given that the closest
sequence homologue of Ex — Willin/FRMD6 — lacks the
PY motifs that are necessary for the interaction between
Ex and the WW domains of Yki [65,67].
dRASSF — the Hippo Antagonist
Optimal kinase activation of the core SWH pathway
members Hpo and Wts requires both association with their
respective co-factors Sav and Mats and assembly into an
apically localised protein complex together with Kibra, Ex
and Mer (see above). Controlling co-factor association there-
fore represents another means of controlling Hpo and Wts
activity. The Drosophila Ras association family (dRASSF)
protein negatively regulates the SWH pathway by competing
with Sav for binding to Hpo via a carboxy-terminal Sav/
Rassf/Hippo (SARAH) domain, shared by all three proteins
[68,69]. When bound to dRASSF, Hpo phosphorylation levels
are low, indicating that Hpo is inactive [68]. As well as
competing for binding to Hpo, dRASSF and Sav negatively
regulate each other at the protein level: rassf clones have
increased Sav levels and, when Sav is overexpressed,
dRASSF levels are lowered [68]. How this reciprocal regula-
tion of protein levels occurs is presently unknown. In addition
to its growth-promoting role through inactivation of Hpo,
dRASSF also appears to have a growth-inhibitory role that
is independent of the SWH pathway, but instead might
depend on Ras signalling [68]. The dual roles of dRASSF as
either an inhibitor or an activator of tissue growth appear
to be conserved among the ten mammalian RASSF homo-
logues. Although the understanding of their cellular functions
is limited, RASSF proteins appear to have functions in tissue
growth and apoptosis that are either dependent on the Hpo
homologues MST1/2, dependent on Ras, or independent of
both MST1/2 and Ras [70–72].
Apico-Basal Polarity Proteins and the SWH Pathway
It has long been known that loss or gain of function of apico-
basal cell polarity regulators — Lgl–Scrib–Dlg, aPKC–
Bazooka–Par6 and Crb–Stardust–PATJ — triggers cell prolif-
eration and/or prevents developmental cell death ([73,74], and
reviewed in [75,76]), but how this occurs is unknown.
Recently, our own study [77] as well as work by Robinson
et al. [78] have revealed that the apico-basal cell polarity
proteins lethal giant larvae (Lgl), aPKC and Crumbs (Crb)
affect cell proliferation and survival by modulating SWH
pathway activity. Interestingly, these proteins were shown to
influence SWH pathway activity in developing Drosophila
epithelial tissues (eye and wing imaginal discs) without grossly
altering cell polarity, suggesting that these proteins modulate
Yki
Time
Ft
Ex
A
With Ex offset
Ex
Ft
Yki
Time
Pr
ot
ei
n 
ac
tiv
ity
Pr
ot
ei
n 
ac
tiv
ity
B
Without Ex offset
Current Biology
Figure 3. A hypothetical model that explains how inhibition of Ft
signalling robustly activates Yki by simultaneously stimulating Yki,
and by offsetting feedback stimulation of Ex.
(A) Temporary reduction of Ft activity concomitantly elevates Yki
activity and reduces Ex activity. Relief of repression of both the Ft
and the Ex arm of upstream SWH signalling allows robust transient
Yki activation above a threshold level that is necessary for Yki-medi-
ated cell proliferation. Because ex is a transcriptional target of Yki,
increased Yki activity would lead to negative feedback regulation of
Yki by increased Ex activity, but only when Ft signalling is reinstated.
Once Ft and Ex activity returns to baseline, then so would repression
of Yki. (B) If the Ex feedback loop was not offset when Ft signalling
was repressed, then Ex would accumulate at higher than normal levels,
by virtue of Yki-dependent activation of ex transcription. High levels of
Ex would be expected to repress Yki and prevent it from triggering cell
proliferation, and possibly even from conferring resistance to
apoptosis.
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tion, the members of the Lgl–Scrib–Dlg complex were shown
to regulate proliferation of Drosophila ovarian follicle cells via
Wts; however, in this situation, cell polarity was lost [79].
aPKC and Lgl regulate SWH pathway activity in an antago-
nistic fashion; Lgl appears to activate the SWH pathway, and
does so by opposing theaction of aPKC (Figure 1). aPKC over-
expression or Lgl depletion results in mislocalisation of both
Hpo and the Hpo inhibitor dRASSF [68], but does not affect
the levelsofseveral otherSWH pathway proteins [77]. Concur-
rent mislocalisation of dRASSF with Hpo would be expected
to prevent Hpo’s association with Sav and therefore prevent
Hpo activation. A better understanding of how aPKC and Lgl
mediate the correct localisation of dRASSF and Hpo will
shed light on their role in growth control via the SWH pathway.
The precise role by which Crb influences SWH pathway
activity and tissue growth is more complex, because overex-
pression of crb and crb deficiency can each lead to elevated
Yki activity. crb overexpression resulted in excess tissue
growth, which was characterised by Crb mislocalisation
and reduced expression of Ex [77,78]. Crb appears to influ-
ence SWH pathway activity independent of Lgl and aPKC,
as Crb overexpression did not perturb Hpo or dRASSF local-
isation [77]. Surprisingly, Robinson et al. [78] also found that
loss of function of crb increased Yki target gene expression,
and resulted in tissue overgrowth. Ex protein abundance
was increased in crb mutants, as expected, but it was aber-
rantly localised basolaterally. Thus, although Ex accumu-
lates in crb mutants, the fact that it is mislocalised suggests
that it may be unable to effectively activate the SWH pathway
or directly repress Yki. Crb affects Ex levels via its juxtamem-
brane FERM-domain-binding motif and, at least in cultured
cells, Crb influences ubiquitin-mediated turnover of Ex [78].
Deregulation of the vertebrate homologues of the Drosophila
apico-basal cell polarity regulators also results in defects in
cell proliferation (reviewed by [75]), although it is not clear
whether these proteins regulate tissue growth in vertebrates
via the SWH pathway.
Cell Tension and the SWH Pathway
Could the Kibra–Ex–Mer complex be regulated by mechan-
ical forces, such as cell tension? Tissue growth in the wing
disc is controlled by a morphogen gradient of Decapentaple-
gic (Dpp) [80]. However, models that rely on Dpp as the sole
instructor of tissue growth cannot be reconciled with some
experimental observations (reviewed in [80]). Tension has
therefore been proposed to be a second dynamic feedback
mechanism that, in addition to Dpp, could regulate tissue
growth [81,82]. Mathematical modelling has predicted that
cell tension increases in a tissue when cells within the tissue
proliferate at unequal rates [83]. If tension was to control cell
proliferation, it could function as a feedback mechanism that
would ensure equal rates of proliferation throughout the
tissue. The regulation of cell proliferation by tension is well
documented in mammalian cultured cells (reviewed in [84]).
In Drosophila, it has so far not been addressed experimen-
tally, owing to technical limitations, but has been postulated
on the basis of computer modelling of tissue growth
[81,82,85]. Moreover, it has been proposed to control the
proliferation of the follicular epithelium that surrounds the
growing Drosophila oocyte [86]. The tension exerted on
a given cell might be sensed by structural components of
cells, such as the actin cytoskeleton. Kibra, Ex and Mer are
located at the interface between the plasma membraneand the cortical actin cytoskeleton and would therefore be
ideally positioned to sense the tensional state of a cell and
could directly translate this information into the regulation
of cell proliferation by the SWH pathway. Novel experimental
strategies, such as ex vivo culture of imaginal discs to allow
experimental modulation of cell tension, are needed in order
to address this possibility. Of note, several studies have
identified potential regulatory links between the SWH
pathway and the actin network and have shown that actin
levels are deregulated in Drosophila epithelial cells that
have perturbed SWH pathway activity ([87,88], F. Janody
and G. Halder, personal communication).
Regulatory Crosstalk Between Upstream Branches
of the SWH Pathway
In future studies it will be important to define the relative
contribution that each upstream branch of the SWH pathway
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R580makes to organ size control, as well as how these branches
interface with each other. Ex, more than any other SWH
pathway member, looms as a protein that has the potential
to mediate regulatory crosstalk between different branches
of the SWH pathway. As described above, Ex is part of the
Kibra–Ex–Mer complex, and can interact with Mer and Kibra,
as well as the core SWH complex, via Hpo [60–62]. The levels
and subcellular localisation of the Ex protein are tightly
controlled at several levels: by the Ft signalling branch, given
that, in wing imaginal disc tissue recessive for ft or dco3, Ex
levels are repressed and less obvious at the apical junction
[29–31,45]; by Crb, which suppresses Ex levels and regulates
its localisation [78]; by Yki activity, which promotes tran-
scription of ex when SWH pathway activity drops [59],
presumably as part of a negative-feedback loop which might
normally reinstate Yki repression following a brief pulse of
Yki activity; in a temporally restricted fashion in the devel-
oping Drosophila eye (Ex levels are lower in the pupal eye
than the larval eye) [63]; and at the level of translation by
the microRNA mir-278 [89].
It should be noted, however, that upstream signalling
inputs impact the core kinase cassette in an Ex-independent
manner. For example, overgrowth of imaginal disc tissues
lacking wts is more severe than of those that lack ex, and
wing imaginal discs mutant for both ft and ex overgrow to
a greater extent than discs lacking either gene alone [45].
This latter finding suggests that Ft and Ex control Yki activity
by responding to different upstream signalling inputs. What
then is the significance of Ft-dependent regulation of Ex
levels for control of organ size? A likely explanation is that
crosstalk occurs between Ft and Ex and Kibra–Ex–Mer
complex signalling to ensure appropriate organ size. One
might imagine that, in response to reduced Ft-mediated
repression of Yki, Ex could at least partially compensate by
activating the core SWH pathway complex, as well as by
directly sequestering Yki. To overcome such compensation
in the face of reduced Ft signalling, a mechanism might
have evolved to concomitantly reduce the abundance of
Ex — both existing Ex protein as well as newly synthesised
Ex generated by the subsequent elevation of Yki activity. It
is conceivable that such a mechanism would ensure perdur-
ance of Yki activity for a critical period of time that would
allow the required activation of tissue growth (see Figure 3
for further details). To test this hypothesis directly, one would
have to disable Ft-mediated regulation of Ex levels and local-
isation and determine the impact on Yki activity and organ
size.
Concluding Remarks
In recent years, our understanding of upstream inputs into
the SWH pathway has expanded rapidly. It is likely that
further upstream regulators of the SWH pathway await
discovery; in mammals, there is evidence that the Wts homo-
logues LATS1/2 can be regulated independently of MST1/2,
and that YAP can be phosphorylated by kinases other than
LATS1/2 [90]. Furthermore, one would expect a phospha-
tase(s) to oppose the phosphorylation of different SWH
pathway proteins. Such proteins might be difficult to
discover using traditional genetic screening techniques
that rely on alterations in tissue growth for two reasons: first,
loss of a single upstream SWH pathway regulatory branch
has only a mild effect on tissue growth (Figure 2), presumably
due to compensatory regulation and feedback loops as
described above; second, novel upstream regulators mighthave pleiotropic functions, such as Ft and Ds in planar cell
polarity, aPKC–Lgl and Crb in apico-basal polarity, or
dRASSF in Ras signalling, which could mask their roles in
SWH signalling. Unconventional screening approaches are
therefore likely to be required to uncover further upstream
regulatory proteins of the SWH pathway.
A facet of growth control mediated by the SWH pathway
that is poorly understood is how its signalling output is inte-
grated with other growth-controlling pathways to co-ordi-
nately define tissue size. Several points of potential crosstalk
have been identified between such pathways and the SWH
pathway: the morphogens, Wg and Dpp, control the expres-
sion of Ds and Fj [26,33], whilst the expression of Wg and the
Notch pathway ligand Ser can be augmented by Yki [44]. Yki
can also modulate morphogen signalling by controlling the
expression of the heparan sulfate proteoglycans Dally and
Dally-like [91]. Furthermore, the expression of Lft, which
controls levels of the Ft and Ds proteins, is controlled by
the Notch and Wg pathways [50], whilst insulin, target of ra-
pamycin, Wg and Notch pathways, in addition to the SWH
pathway, have all been shown to converge on the growth
regulatory microRNA bantam [92–94].
Since its discovery less than 10 years ago, our under-
standing of SWH pathway signalling has grown at an aston-
ishing rate and has allowed the various layers of complexity
inherent in this pathway to begin to be unravelled. Future
studies are sure to identify further intricacies of SWH
pathway signalling which will increase our understanding
of how this pathway impacts tissue growth during normal
development, as well as in human pathologies, such as
cancer.
Acknowledgments
We thank Ryan Galea for help with Figure 1. F.A.G. is supported by an
International Postgraduate Research and Fee Remission Fellowship
from the University of Melbourne, H.E.R. is supported by a Senior
NHMRC Research Fellowship and K.F.H. by a Sylvia and Charles
Viertel Senior Medical Research Fellowship.
References
1. Tapon, N., Harvey, K.F., Bell, D.W., Wahrer, D.C., Schiripo, T.A., Haber, D.A.,
and Hariharan, I.K. (2002). salvador promotes both cell cycle exit and
apoptosis in Drosophila and is mutated in human cancer cell lines. Cell
110, 467–478.
2. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S.A.,
Gayyed, M.F., Anders, R.A., Maitra, A., and Pan, D. (2007). Elucidation of
a universal size-control mechanism in Drosophila and mammals. Cell 130,
1120–1133.
3. Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R.,
and Brummelkamp, T.R. (2007). YAP1 increases organ size and expands
undifferentiated progenitor cells. Curr. Biol. 17, 2054–2060.
4. Harvey, K., and Tapon, N. (2007). The Salvador-Warts-Hippo pathway - an
emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182–191.
5. Zeng, Q., and Hong, W. (2008). The emerging role of the hippo pathway in cell
contact inhibition, organ size control, and cancer development in mammals.
Cancer Cell 13, 188–192.
6. Harvey, K.F., Pfleger, C.M., and Hariharan, I.K. (2003). The Drosophila Mst or-
tholog, hippo, restricts growth and cell proliferation and promotes
apoptosis. Cell 114, 457–467.
7. Udan, R.S., Kango-Singh, M., Nolo, R., Tao, C., and Halder, G. (2003). Hippo
promotes proliferation arrest and apoptosis in the Salvador/Warts pathway.
Nat. Cell Biol. 5, 914–920.
8. Kango-Singh, M., Nolo, R., Tao, C., Verstreken, P., Hiesinger, P.R., Bellen,
H.J., and Halder, G. (2002). Shar-pei mediates cell proliferation arrest during
imaginal disc growth in Drosophila. Development 129, 5719–5730.
9. Pantalacci, S., Tapon, N., and Leopold, P. (2003). The Salvador partner Hippo
promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5,
921–927.
10. Wu, S., Huang, J., Dong, J., and Pan, D. (2003). hippo encodes a Ste-20
family protein kinase that restricts cell proliferation and promotes apoptosis
in conjunction with salvador and warts. Cell 114, 445–456.
Review
R58111. Jia, J., Zhang, W., Wang, B., Trinko, R., and Jiang, J. (2003). The Drosophila
Ste20 family kinase dMST functions as a tumor suppressor by restricting cell
proliferation and promoting apoptosis. Genes Dev. 17, 2514–2519.
12. Lai, Z.C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho,
L.L., and Li, Y. (2005). Control of cell proliferation and apoptosis by mob as
tumor suppressor, mats. Cell 120, 675–685.
13. Huang, J., Wu, S., Barrera, J., Matthews, K., and Pan, D. (2005). The Hippo
signaling pathway coordinately regulates cell proliferation and apoptosis
by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421–434.
14. Wu, S., Liu, Y., Zheng, Y., Dong, J., and Pan, D. (2008). The TEAD/TEF family
protein Scalloped mediates transcriptional output of the Hippo growth-regu-
latory pathway. Dev. Cell 14, 388–398.
15. Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., and Jiang, J. (2008). The
TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling
in organ size control. Dev. Cell 14, 377–387.
16. Goulev, Y., Fauny, J.D., Gonzalez-Marti, B., Flagiello, D., Silber, J., and Zider,
A. (2008). SCALLOPED interacts with YORKIE, the nuclear effector of the
hippo tumor-suppressor pathway in Drosophila. Curr. Biol. 18, 435–441.
17. Peng, H.W., Slattery, M., and Mann, R.S. (2009). Transcription factor choice
in the Hippo signaling pathway: homothorax and yorkie regulation of the mi-
croRNA bantam in the progenitor domain of the Drosophila eye imaginal
disc. Genes Dev. 23, 2307–2319.
18. Zhao, B., Kim, J., Ye, X., Lai, Z.C., and Guan, K.L. (2009). Both TEAD-binding
and WW domains are required for the growth stimulation and oncogenic
transformation activity of yes-associated protein. Cancer Res. 69,
1089–1098.
19. Zhang, X., Milton, C.C., Humbert, P.O., and Harvey, K.F. (2009). Transcrip-
tional output of the Salvador/warts/hippo pathway is controlled in distinct
fashions in Drosophila melanogaster and mammalian cell lines. Cancer
Res. 69, 6033–6041.
20. Pan, D. (2007). Hippo signaling in organ size control. Genes Dev. 21, 886–897.
21. Reddy, B.V., and Irvine, K.D. (2008). The Fat and Warts signaling pathways:
new insights into their regulation, mechanism and conservation. Develop-
ment 135, 2827–2838.
22. Bryant, P.J., Huettner, B., Held, L.I., Jr., Ryerse, J., and Szidonya, J. (1988).
Mutations at the fat locus interfere with cell proliferation control and epithe-
lial morphogenesis in Drosophila. Dev. Biol. 129, 541–554.
23. Clark, H.F., Brentrup, D., Schneitz, K., Bieber, A., Goodman, C., and Noll, M.
(1995). Dachsous encodes a member of the cadherin superfamily that
controls imaginal disc morphogenesis in Drosophila. Genes Dev. 9,
1530–1542.
24. Cho, E., and Irvine, K.D. (2004). Action of fat, four-jointed, dachsous and
dachs in distal-to-proximal wing signaling. Development 131, 4489–4500.
25. Strutt, H., and Strutt, D. (2002). Nonautonomous planar polarity patterning in
Drosophila: dishevelled-independent functions of frizzled. Dev. Cell 3,
851–863.
26. Yang, C.H., Axelrod, J.D., and Simon, M.A. (2002). Regulation of Frizzled by
fat-like cadherins during planar polarity signaling in the Drosophila
compound eye. Cell 108, 675–688.
27. Casal, J., Struhl, G., and Lawrence, P.A. (2002). Developmental compart-
ments and planar polarity in Drosophila. Curr. Biol. 12, 1189–1198.
28. Matakatsu, H., and Blair, S.S. (2006). Separating the adhesive and signaling
functions of the Fat and Dachsous protocadherins. Development 133,
2315–2324.
29. Bennett, F.C., and Harvey, K.F. (2006). Fat cadherin modulates organ size in
Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr. Biol. 16,
2101–2110.
30. Willecke, M., Hamaratoglu, F., Kango-Singh, M., Udan, R., Chen, C.L., Tao,
C., Zhang, X., and Halder, G. (2006). The fat cadherin acts through the hippo
tumor-suppressor pathway to regulate tissue size. Curr. Biol. 16, 2090–2100.
31. Silva, E., Tsatskis, Y., Gardano, L., Tapon, N., and McNeill, H. (2006). The
tumor-suppressor gene fat controls tissue growth upstream of expanded
in the hippo signaling pathway. Curr. Biol. 16, 2081–2089.
32. Willecke, M., Hamaratoglu, F., Sansores-Garcia, L., Tao, C., and Halder, G.
(2008). Boundaries of Dachsous Cadherin activity modulate the Hippo
signaling pathway to induce cell proliferation. Proc. Natl. Acad. Sci. USA
105, 14897–14902.
33. Rogulja, D., Rauskolb, C., and Irvine, K.D. (2008). Morphogen control of wing
growth through the Fat signaling pathway. Dev. Cell 15, 309–321.
34. Matakatsu, H., and Blair, S.S. (2004). Interactions between Fat and Dachsous
and the regulation of planar cell polarity in the Drosophila wing. Development
131, 3785–3794.
35. Ma, D., Yang, C.H., McNeill, H., Simon, M.A., and Axelrod, J.D. (2003). Fidelity
in planar cell polarity signalling. Nature 421, 543–547.
36. Strutt, H., and Strutt, D. (2005). Long-range coordination of planar polarity in
Drosophila. Bioessays 27, 1218–1227.
37. Saburi, S., and McNeill, H. (2005). Organising cells into tissues: new roles for
cell adhesion molecules in planar cell polarity. Curr. Opin. Cell Biol. 17,
482–488.
38. Ishikawa, H.O., Takeuchi, H., Haltiwanger, R.S., and Irvine, K.D. (2008). Four-
jointed is a Golgi kinase that phosphorylates a subset of cadherin domains.
Science 321, 401–404.39. Brittle, A.L., Repiso, A., Casal, J., Lawrence, P.A., and Strutt, D. (2010). Four-
jointed modulates growth and planar polarity by reducing the affinity of
Dachsous for Fat. Curr. Biol. 20, 803–810.
40. Simon, M.A., Xu, A., Ishikawa, H.O., and Irvine, K.D. (2010). Modulation of
Fat:Dachsous binding by the cadherin domain kinase Four-jointed. Curr.
Biol. 20, 811–817.
41. Brodsky, M.H., and Steller, H. (1996). Positional information along the dorsal-
ventral axis of the Drosophila eye: graded expression of the four-jointed
gene. Dev. Biol. 173, 428–446.
42. Lawrence, P.A., Struhl, G., and Casal, J. (2008). Do the protocadherins Fat
and Dachsous link up to determine both planar cell polarity and the dimen-
sions of organs? Nat. Cell Biol. 10, 1379–1382.
43. Casal, J., Lawrence, P.A., and Struhl, G. (2006). Two separate molecular
systems, Dachsous/Fat and Starry night/Frizzled, act independently to
confer planar cell polarity. Development 133, 4561–4572.
44. Cho, E., Feng, Y., Rauskolb, C., Maitra, S., Fehon, R., and Irvine, K.D.
(2006). Delineation of a Fat tumor suppressor pathway. Nat. Genet. 38,
1142–1150.
45. Feng, Y., and Irvine, K.D. (2007). Fat and expanded act in parallel to regulate
growth through warts. Proc. Natl. Acad. Sci. USA 104, 20362–20367.
46. Feng, Y., and Irvine, K.D. (2009). Processing and phosphorylation of the Fat
receptor. Proc. Natl. Acad. Sci. USA 106, 11989–11994.
47. Sopko, R., Silva, E., Clayton, L., Gardano, L., Barrios-Rodiles, M., Wrana, J.,
Varelas, X., Arbouzova, N.I., Shaw, S., Saburi, S., et al. (2009). Phosphoryla-
tion of the tumor suppressor fat is regulated by its ligand Dachsous and the
kinase discs overgrown. Curr. Biol. 19, 1112–1117.
48. Zhai, B., Villen, J., Beausoleil, S.A., Mintseris, J., and Gygi, S.P. (2008). Phos-
phoproteome analysis of Drosophila melanogaster embryos. J. Proteome
Res. 7, 1675–1682.
49. Bodenmiller, B., Malmstrom, J., Gerrits, B., Campbell, D., Lam, H., Schmidt,
A., Rinner, O., Mueller, L.N., Shannon, P.T., Pedrioli, P.G., et al. (2007). Phos-
phoPep–a phosphoproteome resource for systems biology research in
Drosophila Kc167 cells. Mol. Syst. Biol. 3, 139.
50. Mao, Y., Kucuk, B., and Irvine, K.D. (2009). Drosophila lowfat, a novel modu-
lator of Fat signaling. Development 136, 3223–3233.
51. Giot, L., Bader, J.S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y.L.,
Ooi, C.E., Godwin, B., Vitols, E., et al. (2003). A protein interaction map of
Drosophila melanogaster. Science 302, 1727–1736.
52. Matakatsu, H., and Blair, S.S. (2008). The DHHC palmitoyltransferase
approximated regulates Fat signaling and Dachs localization and activity.
Curr. Biol. 18, 1390–1395.
53. Ashery-Padan, R., Alvarez-Bolado, G., Klamt, B., Gessler, M., and Gruss, P.
(1999). Fjx1, the murine homologue of the Drosophila four-jointed gene, co-
des for a putative secreted protein expressed in restricted domains of the
developing and adult brain. Mech. Dev. 80, 213–217.
54. Rock, R., Schrauth, S., and Gessler, M. (2005). Expression of mouse dchs1,
fjx1, and fat-j suggests conservation of the planar cell polarity pathway iden-
tified in Drosophila. Dev. Dyn. 234, 747–755.
55. Saburi, S., Hester, I., Fischer, E., Pontoglio, M., Eremina, V., Gessler, M.,
Quaggin, S.E., Harrison, R., Mount, R., and McNeill, H. (2008). Loss of Fat4
disrupts PCP signaling and oriented cell division and leads to cystic kidney
disease. Nat. Genet. 40, 1010–1015.
56. Ishiuchi, T., Misaki, K., Yonemura, S., Takeichi, M., and Tanoue, T. (2009).
Mammalian Fat and Dachsous cadherins regulate apical membrane organi-
zation in the embryonic cerebral cortex. J. Cell Biol. 185, 959–967.
57. Qi, C., Zhu, Y.T., Hu, L., and Zhu, Y.J. (2009). Identification of Fat4 as a
candidate tumor suppressor gene in breast cancers. Int. J. Cancer 124,
793–798.
58. Nakaya, K., Yamagata, H.D., Arita, N., Nakashiro, K.I., Nose, M., Miki, T., and
Hamakawa, H. (2007). Identification of homozygous deletions of tumor
suppressor gene FAT in oral cancer using CGH-array. Oncogene 26,
5300–5308.
59. Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C.,
Jafar-Nejad, H., and Halder, G. (2006). The tumour-suppressor genes NF2/
Merlin and Expanded act through Hippo signalling to regulate cell prolifera-
tion and apoptosis. Nat. Cell Biol. 8, 27–36.
60. Baumgartner, R., Poernbacher, I., Buser, N., Hafen, E., and Stocker, H.
(2010). The WW domain protein Kibra acts upstream of Hippo in Drosophila.
Dev. Cell 18, 309–316.
61. Genevet, A., Wehr, M.C., Brain, R., Thompson, B.J., and Tapon, N. (2010).
Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev.
Cell 18, 300–308.
62. Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.M., and Pan, D. (2010). Kibra
functions as a tumor suppressor protein that regulates Hippo signaling in
conjunction with Merlin and Expanded. Dev. Cell 18, 288–299.
63. Milton, C.C., Zhang, X., Albanese, N.O., and Harvey, K.F. (2010). Differential
requirement of Salvador-Warts-Hippo pathway members for organ size
control in Drosophila melanogaster. Development 137, 735–743.
64. Pellock, B.J., Buff, E., White, K., and Hariharan, I.K. (2007). The Drosophila
tumor suppressors Expanded and Merlin differentially regulate cell cycle
exit, apoptosis, and Wingless signaling. Dev. Biol. 304, 102–115.
Current Biology Vol 20 No 13
R58265. Badouel, C., Gardano, L., Amin, N., Garg, A., Rosenfeld, R., Le Bihan, T., and
McNeill, H. (2009). The FERM-domain protein Expanded regulates Hippo
pathway activity via direct interactions with the transcriptional activator
Yorkie. Dev. Cell 16, 411–420.
66. Oh, H., Reddy, B.V., and Irvine, K.D. (2009). Phosphorylation-independent
repression of Yorkie in Fat-Hippo signaling. Dev. Biol. 335, 188–197.
67. Gunn-Moore, F.J., Welsh, G.I., Herron, L.R., Brannigan, F., Venkateswarlu,
K., Gillespie, S., Brandwein-Gensler, M., Madan, R., Tavare, J.M., Brophy,
P.J., et al. (2005). A novel 4.1 ezrin radixin moesin (FERM)-containing protein,
‘Willin’. FEBS Lett. 579, 5089–5094.
68. Polesello, C., Huelsmann, S., Brown, N.H., and Tapon, N. (2006). The
Drosophila RASSF homolog antagonizes the hippo pathway. Curr. Biol. 16,
2459–2465.
69. Scheel, H., and Hofmann, K. (2003). A novel interaction motif, SARAH,
connects three classes of tumor suppressor. Curr. Biol. 13, R899–R900.
70. Richter, A.M., Pfeifer, G.P., and Dammann, R.H. (2009). The RASSF proteins
in cancer; from epigenetic silencing to functional characterization. Biochim.
Biophys. Acta 1796, 114–128.
71. Aoyama, Y., Avruch, J., and Zhang, X.F. (2004). Nore1 inhibits tumor cell
growth independent of Ras or the MST1/2 kinases. Oncogene 23,
3426–3433.
72. Ikeda, M., Kawata, A., Nishikawa, M., Tateishi, Y., Yamaguchi, M.,
Nakagawa, K., Hirabayashi, S., Bao, Y., Hidaka, S., Hirata, Y., et al. (2009).
Hippo pathway-dependent and -independent roles of RASSF6. Sci.
Signaling 2, ra59.
73. Grzeschik, N.A., and Knust, E. (2005). IrreC/rst-mediated cell sorting during
Drosophila pupal eye development depends on proper localisation of DE-
cadherin. Development 132, 2035–2045.
74. Grzeschik, N.A., Amin, N., Secombe, J., Brumby, A.M., and Richardson, H.E.
(2007). Abnormalities in cell proliferation and apico-basal cell polarity are
separable in Drosophila lgl mutant clones in the developing eye. Dev. Biol.
311, 106–123.
75. Humbert, P.O., Grzeschik, N.A., Brumby, A.M., Galea, R., Elsum, I., and
Richardson, H.E. (2008). Control of tumourigenesis by the Scribble/Dlg/Lgl
polarity module. Oncogene 27, 6888–6907.
76. Assemat, E., Bazellieres, E., Pallesi-Pocachard, E., Le Bivic, A., and Massey-
Harroche, D. (2008). Polarity complex proteins. Biochim. Biophys. Acta 1778,
614–630.
77. Grzeschik, N.A., Parsons, L.M., Allott, M.L., Harvey, K.F., and Richardson,
H.E. (2010). Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo
pathway through two distinct mechanisms. Curr. Biol. 20, 573–581.
78. Robinson, B.S., Huang, J., Hong, Y., and Moberg, K.H. (2010). Crumbs regu-
lates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain
protein expanded. Curr. Biol. 20, 582–590.
79. Zhao, M., Szafranski, P., Hall, C.A., and Goode, S. (2008). Basolateral junc-
tions utilize warts signaling to control epithelial-mesenchymal transition
and proliferation crucial for migration and invasion of Drosophila ovarian
epithelial cells. Genetics 178, 1947–1971.
80. Affolter, M., and Basler, K. (2007). The Decapentaplegic morphogen
gradient: from pattern formation to growth regulation. Nat. Rev. Genet. 8,
663–674.
81. Hufnagel, L., Teleman, A.A., Rouault, H., Cohen, S.M., and Shraiman, B.I.
(2007). On the mechanism of wing size determination in fly development.
Proc. Natl. Acad. Sci. USA 104, 3835–3840.
82. Aegerter-Wilmsen, T., Aegerter, C.M., Hafen, E., and Basler, K. (2007). Model
for the regulation of size in the wing imaginal disc of Drosophila. Mech. Dev.
124, 318–326.
83. Shraiman, B.I. (2005). Mechanical feedback as a possible regulator of tissue
growth. Proc. Natl. Acad. Sci. USA 102, 3318–3323.
84. Mammoto, A., and Ingber, D.E. (2009). Cytoskeletal control of growth and
cell fate switching. Curr. Opin. Cell Biol. 21, 864–870.
85. Aegerter-Wilmsen, T., Smith, A.C., Christen, A.J., Aegerter, C.M., Hafen, E.,
and Basler, K. (2010). Exploring the effects of mechanical feedback on
epithelial topology. Development 137, 499–506.
86. Wang, Y., and Riechmann, V. (2007). The role of the actomyosin cytoskeleton
in coordination of tissue growth during Drosophila oogenesis. Curr. Biol. 17,
1349–1355.
87. Yang, X., Yu, K., Hao, Y., Li, D.M., Stewart, R., Insogna, K.L., and Xu, T.
(2004). LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.
Nat. Cell Biol. 6, 609–617.
88. Fang, X., and Adler, P.N. (2010). Regulation of cell shape, wing hair initiation
and the actin cytoskeleton by Trc/Fry and Wts/Mats complexes. Dev. Biol.
341, 360–374.
89. Teleman, A.A., Maitra, S., and Cohen, S.M. (2006). Drosophila lacking micro-
RNA miR-278 are defective in energy homeostasis. Genes Dev. 20, 417–422.
90. Zhou, D., Conrad, C., Xia, F., Park, J.S., Payer, B., Yin, Y., Lauwers, G.Y.,
Thasler, W., Lee, J.T., Avruch, J., et al. (2009). Mst1 and Mst2 maintain hepa-
tocyte quiescence and suppress hepatocellular carcinoma development
through inactivation of the Yap1 oncogene. Cancer Cell 16, 425–438.
91. Baena-Lopez, L.A., Rodriguez, I., and Baonza, A. (2008). The tumor
suppressor genes dachsous and fat modulate different signalling pathways
by regulating dally and dally-like. Proc. Natl. Acad. Sci. USA 105, 9645–9650.92. Herranz, H., Perez, L., Martin, F.A., and Milan, M. (2008). A Wingless and
Notch double-repression mechanism regulates G1-S transition in the
Drosophila wing. EMBO J. 27, 1633–1645.
93. Nolo, R., Morrison, C.M., Tao, C., Zhang, X., and Halder, G. (2006). The
bantam microRNA is a target of the hippo tumor-suppressor pathway.
Curr. Biol. 16, 1895–1904.
94. Thompson, B.J., and Cohen, S.M. (2006). The Hippo pathway regulates the
bantam microRNA to control cell proliferation and apoptosis in Drosophila.
Cell 126, 767–774.
95. McCartney, B.M., Kulikauskas, R.M., LaJeunesse, D.R., and Fehon, R.G.
(2000). The neurofibromatosis-2 homologue, Merlin, and the tumor
suppressor expanded function together in Drosophila to regulate cell prolif-
eration and differentiation. Development 127, 1315–1324.
